---
title: Improve walking via robotic exoskeleton
nct_id: NCT06225830
phase: NA
status: RECRUITING
sponsor: Albert Einstein Healthcare Network
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06225830"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06225830"
last_fetched: "2026-05-10T14:01:54.845Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking via robotic exoskeleton

**Goal (in five words):** Improve walking via robotic exoskeleton

**Official Title:** Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease

**Trial ID:** [NCT06225830](https://clinicaltrials.gov/study/NCT06225830)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Albert Einstein Healthcare Network
- **Target Enrollment:** 24 participants
- **Start Date:** 2024-06-04
- **Completion Date:** 2026-06
- **Conditions:** Parkinson Disease
- **Interventions:** Eksobionics Eksoskeleton NR
- **Intervention Types:** DEVICE

## Summary For Families

The goal is to improve walking and balance by giving people with Parkinson's much more high-intensity, complex gait practice than they can do safely on their own. The approach uses the Ekso wearable robotic exoskeleton to support and assist hip and leg movements so you can stand and take many more steps at a hard effort, helping retrain walking circuits and build endurance; sessions are 45 to 60 minutes with about 30 minutes at RPE 14 to 17, and the therapy is meant to complement your usual Parkinson's medications. They are enrolling adults over 18 with a physician diagnosis of idiopathic Parkinson's who report walking or balance problems, can tolerate at least 15 minutes upright and use a front-wheeled walker, and who fit device limits (under 220 pounds, roughly 5'0" to 6'4"), while people with major cognitive, neurological, cardiovascular, or musculoskeletal issues that make exoskeleton use unsafe are excluded.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

1. Physician diagnosed idiopathic Parkinson's disease
2. All Hoehn and Yahr (H\&Y) stages will be eligible for inclusion in the study
3. Able to consent to participation in the research study
4. Pt agreeable to participate in 45-60 minutes of high intensity (RPE 14-17 for 30 minutes) gait training/ physical therapy.
5. Sufficient upper extremity strength to use a front wheeled walker
6. Pt to have self- reported walking/balance deficits
7. Age: Over age 18
8. Must be able to tolerate at least 15 min upright
9. Weigh 220 pounds (100kg) or less
10. Approximately between 5'0" and 6'4" tall
11. Have near normal range of motion in hips, knees, and ankles "Can you stand up and straighten your knees even for just a second?" or "Can you lay flat and straighten your knees so there is no bend in the knee?"

Exclusion Criteria:

1. Currently involved in another intervention study or physical therapy course of care
2. Concurrent neurological disease
3. Leg length discrepancy, self-reported.
4. Spinal instability
5. Unresolved deep vein thrombosis
6. Severe muscular or skeletal pain
7. Open skin ulcerations on buttocks or other body surfaces in contact with exoskeleton or harness
8. Pregnancy
9. Cognitive impairments - unable to follow 2 steps commands and communicate for pain or to stop session
10. Participant requires the assistance of more than one therapist to transfer safely.
11. Uncontrolled or severe orthostatic hypotension that limits standing tolerance; defined as sustained, symptomatic drops in systolic and diastolic blood pressure when moving from sitting to standing
12. Active heterotrophic ossification (HO), hip dysplasia or hip/knee axis abnormalities
13. Colostomy
14. History of long bone fractures secondary to osteoporosis
15. Unable to sustain current medication regimen. Participant reports change in Parkinson's Medication in the past week.
16. Any reason the therapist may deem as harmful to the participant to enroll or continue in the study
```

## Locations (1)

- Jefferson Moss-Magee Rehabilitation - Elkins Park, Elkins Park, Pennsylvania, United States _(40.0771, -75.1268)_
  - Jacqueline Brown, DPT — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Jacqueline Brown, DPT — (CONTACT) — 215-663-6575 — Jxb892@jefferson.edu
- Kris Ferrara, DPT — (CONTACT) — 215-663-6575 — Kristopher.Ferrara@jefferson.edu

---

*Canonical: https://parkinsonspathways.com/trial/NCT06225830*  
*HTML version: https://parkinsonspathways.com/trial/NCT06225830*  
*Source data: https://clinicaltrials.gov/study/NCT06225830*